- Oncology Nevada adds 2 radiation specialists in Reno
- New York system opens specialty pharmacy
- 13 behavioral health services, facility closures | 2026
- WVU Health to pay $4.2M settlement, overhaul drug controls after DEA probe
- Arizona system promotes 2 executives
- Hillsboro Medical Center to close 21-bed geriatric psych unit
- A PE-backed buyer approaches your ASC. Do you take the meeting?
- 10 things to know about the nurse faculty shortage
- South Carolina VA health system wins AHA quality prize; 3 systems named finalists
- Why 720 rural hospitals are at risk of closing
- 16 maternity service closures in 2026
- Dartmouth Cancer Center raises record $12M for research
- George Washington University Hospital CFO exits
- 19 state behavioral health policy updates
- The regulatory loophole fueling the office-based surgery center boom
- Ohio orthopedics MOB sold for $9.9M
- Salt Dental Partners adds Maryland pediatric dental group
- 9 federal government, policy updates to know
- Atrium Health, OrthoCarolina to launch ASC joint venture
- This population doesn’t know 988 exists: 5 things to know
- 17 dentists making headlines
- Dentistry is 35% consolidated: 7 notes on the state of dental M&A
- UC Davis expands GI service line
- North Carolina drops pre-approval requirement for DSO agreements
- Minnesota AG secures refunds for patients of dental practice that closed without notice
- New Florida ASC expands orthopedic offerings
- MSO acquires 2 physician-owned practices
- Physician among charged in $20M kickback, unnecessary prescription scheme
- Reducing orthopedic coding denials with AI — 4 takeaways
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- Germany pushes through healthcare reform package despite pharma's drug discount resistance
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- Smartphones Can Increase Seniors' Risk Of Depression
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Pro Soccer Players Show Signs Of Shrinking Brains
- A New Option For Long-Term Care Costs
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Digital health funding hits $7.4B in 2026 as AI investment reshapes the market
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- 15 states sue US Education Department over mental health cuts
- 23 new behavioral health study findings to know
- Illinois grows certified recovery support workforce 335% since 2022
- New Mexico awards $24.5M for behavioral health expansion
- 38 behavioral health executive moves to know
- Payers are pushing top anesthesiologists out of the insurance model
- Virginia’s largest dental group adds Overjet AI platform
- My Community Dental Centers appoints chief people officer
- Former Illinois dental employee pleads guilty to stealing more than $500K from practice
- U of Maryland appoints interim dental school dean
- What leaders need to know about rising mental health leave
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Regulatory tracker: NICE urges against future Lumakras reimbursement in UK
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
Michigan healthcare freedom community forum
Abortions are illegal in Georgia after 6 weeks of pregnancy. Here we have the sad case of a woman who gave birth to a premature girl well after that period with "major health issues," after taking misoprostol and illegal oxycodone. This case could set legal precedents, depending upon the full facts of the matter and the progression of legal process:
Georgia woman faces murder charge after taking abortion pill
By Jasper Ward - March 21, 2026Summary
- Advocacy group calls charges 'cruel and unjust'
- Georgia has a ban on nearly all abortions
- Newborn was reportedly born at 22- to 24-weeks gestation
- Woman told friend she did not want another child, police say
March 20 (Reuters) - A 31-year-old Georgia woman has been charged with murder after she took abortion medication and gave birth to a premature infant who died within hours, according to court documents and arrest records.
Alexia Moore was arrested, charged and jailed by local police earlier this month in coastal Camden County, Georgia, near the Florida border over the episode on December 30.
Nearly all abortions in Georgia are illegal after six weeks of pregnancy. Since the U.S. Supreme Court's overturned Roe v. Wade in 2022, eliminating the constitutional right to abortion, many states have adopted abortion bans.
While other states have sought to prosecute women who had abortions, it is rare they are charged with murder as Moore was. It will be up to state prosecutors to decide whether to move forward with the case.
Moore, who already has two young children, took the abortion medication misoprostol at home then was rushed to the Southeast Georgia Health System Camden Campus on December 30, after experiencing severe pain, according to a police report.
She informed staff of her pregnancy and said she had taken 200 mg of misoprostol before arriving at the emergency room. A friend later told police that Moore took the abortion pill because she did not want another child.
While at the health center, the 31-year-old gave birth to a premature girl who police described as having "major health issues." Police said Moore also took illegal oxycodone, an opioid.
The newborn survived about an hour. The police report did not indicate weeks of gestation for the infant, but the Washington Post reported that Moore was between 22 and 24 weeks pregnant.
A lawyer for Moore could not immediately be reached for comment.
Dana Sussman, senior vice president at advocacy group Pregnancy Justice, said the Georgia case has no basis in the law and that it should be met with a vigorous defense on several grounds.
Georgia's abortion law "does not contemplate murder charges for someone who has an abortion, and self-managing an abortion is not a criminal act in Georgia. Charging Ms. Moore with murder is cruel and unjust," Sussman said in a statement.
Legal action by states that have banned or restricted abortion has largely been targeted at providers, including doctors who prescribe abortion medications remotely and dispense them through the mail.
Meanwhile, several Republican-led states including Texas and Florida are pursuing legal challenges to federal rules that have eased access to abortion drugs, including a 2023 regulation allowing them to be dispensed through the mail.
Judge Orders $ 1 Bond For Murder Charge Plus $ 2,000 Bond For 2 Drug Charges:
Judge grants $1 murder bond for Georgia woman accused of using pills to induce second-trimester abortion
Alexia Moore, 31, was approximately five months pregnant, according to a police warrant
By Landon Mion - March 24, 2026A Georgia judge granted a bond of only $1 to a woman charged with murder after she allegedly took pills to induce an abortion at approximately five months pregnant, which is illegal under the state's abortion restrictions.
Alexia Moore, 31, has spent nearly three weeks behind bars in coastal Camden County after her arrest on March 4, when police used an arrest warrant with language that mirrors the state's abortion ban after six weeks gestation.
"I think that charge is extremely problematic," Superior Court Judge Steven Blackerby said of the murder charge during a bond hearing on Monday, according to The New York Times.
"That is going to be a hard charge to convict upon," the judge continued.
Blackerby set Moore's total bond at $2,001, ordering $1,000 bond amounts for each of her two drug charges on top of the murder charge.
Moore's case is among the first in Georgia of a woman facing charges for terminating a pregnancy since the Peach State's abortion ban was adopted in 2019, banning abortions after embryonic cardiac activity can be detected, which is typically at about six weeks gestation.
District Attorney Keith Higgins of the Brunswick Judicial Circuit did not challenge the $1 bond in court on Monday and told the judge that police did not contact his office before charging Moore, according to reports.
Higgins' office would need to obtain a grand jury indictment before it could take Moore to trial.
Moore posted bond and was released on Monday, jail records show.
"Today’s decision is a reminder that justice is not served by accusation alone," attorneys from the Georgia Public Defender Council, who are representing Moore, said in a statement.
"Our system works best when courts carefully weigh the facts, uphold constitutional protections, and safeguard the rights of every person who comes before them," the statement added.
Moore arrived at a hospital on Dec. 30 and said she was suffering from abdominal pain, according to court records. She told hospital staff that she took misoprostol, a drug used to cause abortions, and the opioid painkiller oxycodone, according to an arrest warrant obtained by police in Kingsland, Georgia.
The baby survived for about an hour after being delivered at the hospital, according to the warrant.
The warrant states that police obtained medical records estimating that Moore had been pregnant for 22 to 24 weeks. The document also cited "the medical staff’s knowledge that the baby had a beating heart and was struggling to breathe."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























